Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f8c88c56a0153433ac84e648859ce17 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00 |
filingDate |
2007-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6f6ea7202723d114265afddd97f1e0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb54c11e06addcd3a67c4358afae1320 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_006d45dc07924ae15359c967a76d486d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7529708704e6dd712adb632748effc0d |
publicationDate |
2010-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-101641106-A |
titleOfInvention |
Anti-TSG101 antibodies and their uses for treatment of viral infections |
abstract |
The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112630449-A |
priorityDate |
2006-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |